Shiran ShapiraCTO/CSO at Nano24Speaker
Agenda Sessions
[Clinical Case Study] Targeted by Nature, Powered by Innovation: EXO-CD24 Is Pioneering a New Class of Exosome-Based Therapies
, 16:45View Session
[Clinical Case Study] Targeted by Nature, Powered by Innovation: EXO-CD24 Is Pioneering a New Class of Exosome-Based Therapies